March 2, 2024

Wireless Implants Market Size To Reach USD 29.51 Bn By 2032

The global wireless implants market size was valued at USD 6.70 billion in 2023 and is expected to reach around USD 29.51 billion by 2032, growing a CAGR of 17.90% during the forecast period from 2023 to 2032.

Wireless Implants Market Size 2023 To 2032

Key Takeaways

  • North America contributed more than 41% of revenue share in 2022.
  • Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By application, the orthopedic implants segment has held the largest market share of 45% in 2022.
  • By application, the cardiovascular implants segment is anticipated to grow at a remarkable CAGR of 18.4% between 2023 and 2032.
  • By end-user, the hospitals segment generated over 36% of revenue share in 2022.
  • By end-user, the clinics segment is expected to expand at the fastest CAGR over the projected period.

The wireless implants market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market

The study offers intricate dynamics about different aspects of the global wireless implants market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global wireless implants market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3618

Wireless Implants Market Scope

Report CoverageDetails
Growth Rate from 2023 to 2032CAGR of 17.90%
Market Size in 2023USD 6.70 Billion
Market Size by 2032USD 29.51 Billion
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Application and By End-User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

This study covers an elaborate segmentation of the global wireless implants market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global wireless implants market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.

Read Also: Submersible Pumps Market Size To Surpass USD 19.40 Bn By 2032

Recent Developments

  • In May 2023, Medtronic made a strategic move by acquiring Ablation Frontiers, a pioneer in minimally invasive ablation technologies designed for treating atrial fibrillation. This acquisition is anticipated to reinforce Medtronic’s standing within the cardiovascular implant market. By integrating Ablation Frontiers’ innovative solutions, Medtronic aims to diversify its product portfolio, offering advanced treatments for a prevalent heart condition.
  • In a parallel development in April 2023, Abbott Laboratories expanded its foothold in the healthcare sector by acquiring Verifi Medical. Verifi Medical specializes in developing neuromodulation devices tailored for chronic pain management. Abbott’s acquisition is poised to broaden its range of pain management solutions and fortify its position in the competitive neuromodulation market, demonstrating the company’s commitment to advancing medical technologies for enhanced patient care.

Wireless Implants Market Players

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Limited
  • Zimmer Biomet Holdings, Inc.
  • St. Jude Medical (now part of Abbott)
  • Dexcom, Inc.
  • Siemens Healthineers
  • LivaNova PLC
  • NXP Semiconductors
  • Biotronik SE & Co. KG
  • Ekso Bionics Holdings, Inc.
  • MicroPort Scientific Corporation
  • Nevro Corp.
  • Sensirion AG

Segments Covered in the Report

By Application

  • Orthopedic Implants
  • Cardiovascular Implants
  • Neurological Implants
  • Other implants

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology acquire by analysts for assemble the global wireless implants market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global wireless implants market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Wireless Implants Market 

5.1. COVID-19 Landscape: Wireless Implants Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Wireless Implants Market, By Application

8.1. Wireless Implants Market Revenue and Volume, by Application, 2023-2032

8.1.1. Orthopedic Implants

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Cardiovascular Implants

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Neurological Implants

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Other implants

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Wireless Implants Market, By End-User

9.1. Wireless Implants Market Revenue and Volume, by End-User, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Ambulatory Surgical Centers

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Clinics

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Wireless Implants Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

Chapter 11. Company Profiles

11.1. Medtronic

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Abbott Laboratories

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Boston Scientific Corporation

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Cochlear Limited

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Zimmer Biomet Holdings, Inc.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. St. Jude Medical (now part of Abbott)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Dexcom, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Siemens Healthineers

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. LivaNova PLC

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. NXP Semiconductors

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com